Morison Industries Plc

MORISON

NGMORISON000

Pharmaceuticals

End-of-day quote Nigerian S.E. Other stock markets 23:00:00 30/05/2024 BST			5-day change	1st Jan Change
4.45 ^NGN	-.--%		+9.88%	+58.93%

01-25	Morison Industries Plc Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI
2023	Morison Industries Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Morison Industries Plc Names Afolake Lawal as Non-Executive Director

September 14, 2018 at 11:30 am

Morison Industries Plc has appointed Afolake Lawal as its non-executive director. Currently, Lawal serves at Eterna Plc as a board member.

Latest news about Morison Industries Plc

Morison Industries Plc Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	01-25	CI
Morison Industries Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	26/10/23	CI
Morison Industries Plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	27/07/23	CI
Morison Industries Plc Reports Earnings Results for the First Quarter Ended March 31, 2023	13/06/23	CI
Morison Industries Plc Auditor Raises 'Going Concern' Doubt	12/06/23	CI
Morison Industries Plc Reports Earnings Results for the Full Year Ended December 31, 2022	27/01/23	CI
Morison Industries Plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	27/01/23	CI
Morison Industries Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	28/10/22	CI
Morison Industries Plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	28/07/22	CI
Morison Industries Plc Reports Earnings Results for the First Quarter Ended March 31, 2022	26/04/22	CI
Morison Industries Plc Reports Earnings Results for the Full Year Ended December 31, 2021	01/02/22	CI
Morison Industries Plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	01/02/22	CI
Morison Industries plc Reports Earnings Results for the Second Quarter Ended June 30, 2021	30/07/21	CI
Morison Industries plc Reports Earnings Results for the First Quarter Ended March 31, 2021	27/04/21	CI
Morison Industries plc Reports Earnings Results for the Full Year Ended December 31, 2020	01/04/21	CI
Morison Industries plc Reports Earnings Results for the Third Quarter Ended September 30, 2020	03/11/20	CI
Morison Industries plc Reports Earnings Results for the Second Quarter Ended June 30, 2020	29/07/20	CI
Morison Industries plc Reports Earnings Results for the First Quarter Ended March 31, 2020	25/06/20	CI
Morison Industries plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2019	03/02/20	CI
Morison Industries plc Reports Earnings Results for the Third Quarter Ended September 30, 2019	30/10/19	CI
Morison Industries plc Reports Earnings Results for the Second Quarter Ended June 30, 2019	30/07/19	CI
Morison Industries plc Reports Earnings Results for the Full Year Ended December 31, 2018	02/04/19	CI
Morison Industries Plc Names Afolake Lawal as Non-Executive Director	14/09/18	CI
Morison Industries Plc Auditor Raises 'Going Concern' Doubt	01/04/15	CI

Morison Industries Plc specializes in manufacturing and marketing pharmaceutical, hygiene and care products. The group's products include primarily medical and surgical care products, detergents, disinfectants and insecticides. Net sales break down by family of products as follows: - consumer products (71.5%); - pharmaceuticals (4.8%); - other (23.7%). All sales are earned in Nigeria.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
MORISON INDUSTRIES PLC	+58.93%	3.33M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+15.91%	42.02B
OTSUKA HOLDINGS CO., LTD.	+22.40%	21.66B
SANDOZ GROUP AG	+18.48%	15.09B
CIPLA LIMITED	+16.12%	14.21B
ZYDUS LIFESCIENCES LIMITED	+45.12%	12.37B
THE MEDICINES COMPANY	-0.05%	6.79B
ONO PHARMACEUTICAL CO., LTD.	-9.58%	6.59B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+14.18%	5.56B